Millions of U.S. seniors were supposed to get price relief soon on their prescription drugs under a revamp of Medicare fees by a federal agency. The Centers for Medicaid and Medicare Services delayed proposed changes until 2024 at least. The trade group for PBMs– the Pharmaceutical Care Management Association– applauded the deal.
Pharmacists and technicians, who have played a critical role in administering Covid-19 tests and vaccines, say they are burned out nearly two years into the pandemic.
In a surprise move, a top federal regulator promises to delve into extensive fees assessed on pharmacies by drug-chain middlemen in what could be the first
VendRx sounds convenient But it could pervert physician incentives slate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from slate.com Daily Mail and Mail on Sunday newspapers.